Search Results - Pypstra, Rienk

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    Results of a Double-Blind, Randomized Trial of Ceftobiprole Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive Bacteria

    Results of a Double-Blind, Randomized Trial of Ceftobiprole Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive Bacteria by NOEL, Gary J, STRAUSS, Richard S, AMSLER, Karen, HEEP, Markus, PYPSTRA, Rienk, SOLOMKIN, Joseph S

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19

    Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19 by Hammond, Jennifer, Leister-Tebbe, Heidi, Gardner, Annie, Abreu, Paula, Bao, Weihang, Wisemandle, Wayne, Baniecki, MaryLynn, Hendrick, Victoria M, Damle, Bharat, Simón-Campos, Abraham, Pypstra, Rienk, Rusnak, James M

    Request full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Probability of Target Attainment for Ceftobiprole as Derived from a Population Pharmacokinetic Analysis of 150 Subjects

    Probability of Target Attainment for Ceftobiprole as Derived from a Population Pharmacokinetic Analysis of 150 Subjects by LODISE, Thomas P, PYPSTRA, Rienk, KAHN, James B, MURTHY, Bindu P, KIMKO, Hui C, BUSH, Karen, NOEL, Gary J, DRUSANO, George L

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Summary of the safety and tolerability of two treatment regimens of ceftaroline fosamil: 600 mg every 8 h versus 600 mg every 12 h

    Summary of the safety and tolerability of two treatment regimens of ceftaroline fosamil: 600 mg every 8 h versus 600 mg every 12 h by Cheng, Karen, Pypstra, Rienk, Yan, Jean Li, Hammond, Jennifer

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Alleviation of COVID-19 Symptoms and Reduction in Healthcare Utilization Among High-Risk Patients Treated With Nirmatrelvir/Ritonavir (NMV/R): A phase 3 randomized trial

    Alleviation of COVID-19 Symptoms and Reduction in Healthcare Utilization Among High-Risk Patients Treated With Nirmatrelvir/Ritonavir (NMV/R): A phase 3 randomized trial by Hammond, Jennifer, Leister-Tebbe, Heidi, Gardner, Annie, Abreu, Paula, Bao, Weihang, Wisemandle, Wayne, Ansari, Wajeeha, Harrington, Magdalena Alicja, Simón-Campos, Abraham, Chew, Kara W, Pypstra, Rienk, Rusnak, James M

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Aztreonam–avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial

    Aztreonam–avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomis... by Carmeli, Yehuda, Cisneros, José Miguel, Paul, Mical, Daikos, George L, Wang, Minggui, Torre-Cisneros, Julian, Singer, George, Titov, Ivan, Gumenchuk, Illia, Zhao, Yongjie, Jiménez-Rodríguez, Rosa-María, Liang, Lu, Chen, Gang, Pyptiuk, Oleksandr, Aksoy, Firdevs, Rogers, Halley, Wible, Michele, Arhin, Francis F, Luckey, Alison, Leaney, Joanne L, Pypstra, Rienk, Chow, Joseph W, Bonten, Marc, Rodríguez-Baño, Jesús, Lammens, Christine, Goossens, Herman, Malhotra-Kumar, Surbhi

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  7. 7
    786. Effect of Nirmatrelvir/Ritonavir versus Placebo on COVID-19─Related Hospitalizations and Other Medical Visits

    786. Effect of Nirmatrelvir/Ritonavir versus Placebo on COVID-19─Related Hospitalizations and Other Medical Visits by Hammond, Jennifer, Leister-Tebbe, Heidi, Gardner, Annie, Abreu, Paula, Bao, Weihang, Wisemandle, Wayne, Ansari, Wajeeha, Simón Campos, Jesus Abraham, Pypstra, Rienk, Rusnak, James M

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    1156. Sustained Alleviation and Resolution of Targeted COVID-19 Symptoms with Nirmatrelvir/Ritonavir versus Placebo

    1156. Sustained Alleviation and Resolution of Targeted COVID-19 Symptoms with Nirmatrelvir/Ritonavir versus Placebo by Hammond, Jennifer, Leister-Tebbe, Heidi, Gardner, Annie, Abreu, Paula, Bao, Weihang, Wisemandle, Wayne, Ansari, Wajeeha, Harrington, Magdalena Alicja, Campos, Jesus Abraham Simón, Chew, Kara W, Pypstra, Rienk, Rusnak, James M

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  9. 9
    2893 A. Efficacy and Safety of Aztreonam-Avibactam for the Treatment of Serious Infections Due to Gram-Negative Bacteria, Including Metallo-β-Lactamase-Producing Pathogens: Phase 3 REVISIT Study

    2893 A. Efficacy and Safety of Aztreonam-Avibactam for the Treatment of Serious Infections Due to Gram-Negative Bacteria, Including Metallo-β-Lactamase-Producing Pathogens: Phase 3... by Carmeli, Yehuda, Cisneros, Jose-Miguel, Paul, Mical, Daikos, Georgios L, Wang, Minggui, Cisneros, Julian Torre, Singer, George, Titov, Ivan, Gumenchuk, Illia, Zhao, Yongjie, Jiménez Rodríguez, Rosa-María, Liang, Lu, Chen, Gang, Pyptiuk, Oleksandr, Aksoy, Firdevs, Rogers, Halley, Wible, Michele, Arhin, Francis, Luckey, Alison, Leaney, Joanne, Pypstra, Rienk, Chow, Joseph

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  10. 10
    Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: A randomized, open-label, multicenter study of clinical efficacy and tolerability

    Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquir... by Lode, Hartmut, File, Thomas M, Mandell, Lionel, Ball, Peter, Pypstra, Rienk, Thomas, Michael

    Published in Clinical therapeutics
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  11. 11
    Augmentin® (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent

    Augmentin® (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent... by White, Anthony R., Kaye, Clive, Poupard, James, Pypstra, Rienk, Woodnutt, Gary, Wynne, Brian

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: